Item 4 — Purpose of Transaction
Item 4 is hereby amended and supplemented by adding the following thereto: On June 12, 2026, the Court of Milan granted interim relief suspending the effectiveness of the resolution adopted at the Issuer's extraordinary shareholders' meeting on October 29, 2025 concerning the amendment to the Issuer's corporate purpose. On July 9, 2026, a panel of the Court of Milan revoked that interim relief following a challenge filed by the Issuer. The proceedings on the merits remain pending. Between August 7, 2026 and August 19, 2026, Fin Posillipo S.p.A. ("Posillipo") acquired 110,000 ADSs in open-market transactions at a price of $1.30 per ADS. Posillipo made these purchases for its own account. The purchases were not planned, directed, or coordinated by, and were not made pursuant to any agreement or understanding with, any other Reporting Person. The other Reporting Persons were not aware of the purchases until September 28, 2026. Posillipo made the purchases for its own investment purposes and not in furtherance of the objectives of the group described in Item 4 of the Schedule 13D. Details of the acquisition are included in Items 3 and 5 of this Amendment No. 1.